NK/T-CELL LYMPHOMA
Clinical trials for NK/T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NK/T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for NK/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to cut relapse in rare lymphoma
Disease control ENROLLING_BY_INVITATIONThis study tests whether adding the drug tislelizumab to standard chemotherapy and radiation can improve outcomes for people with early-stage NK/T-cell lymphoma, a rare blood cancer. About 60 adults aged 18 to 70 will receive the combination treatment. The goal is to see if this …
Matched conditions: NK/T-CELL LYMPHOMA
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New hope for tough lymphomas: GNC-038 trial underway
Disease control OngoingThis study tests an experimental drug called GNC-038 in people with certain types of lymphoma that have come back or stopped responding to treatment. The main goals are to find safe dose levels and see if the drug can shrink tumors. The trial is for adults aged 18 to 75 with NK/T…
Matched conditions: NK/T-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New blood test could help monitor T-Cell lymphoma
Knowledge-focused OngoingThis study looks at whether a new blood test can find tiny bits of tumor DNA in people with T-cell lymphoma. The goal is to see if this test can help doctors track how well treatment is working and watch for signs of the cancer coming back. About 50 adults with newly diagnosed or…
Matched conditions: NK/T-CELL LYMPHOMA
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC